Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...
RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...